ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MS Trusts names first sites for specialist nurse scheme
April 27, 2017The MS Trust has announced that Leicester and Bradford are the first sites chosen for its multiple sclerosis specialist nurse... -
Novartis real-world data at AAN confirms benefit of Gilenya® on four key measures of disease activit
April 25, 2017Novartis today announced data from the Phase IV Multiple Sclerosis and clinical outcome and MRI in the US (MS-MRIUS) study, which confirmed the effectiveness of Gilenya® (fingolimod) in the real-world setting, supporting previous findings from Phase III t -
Immune-Based Therapy Shows Early Promise Against MS
April 21, 2017An experimental immune-system therapy appears safe for people with progressive forms of multiple sclerosis. And it may ease symptoms in some, a preliminary study suggests.
Pharma Sources Insight January 2025
